NN
Nexus NeuroTech Ventures
· Venture Capitalnexusneurotech.com
About
Founded in 2023 by Jordi Parramon, PhD and William Marks, MD and with the addition of Jon Lundt, PhD, the firm brings a deep commitment to helping those with neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, such as Parkinson’s disease, bipolar disorder, and autism spectrum disorder. Adjacent to these sentinel disorders are many other brain disorders that are also within scope for Nexus NeuroTech Ventures.
Investment Activity
Investment rounds, fund raises, and portfolio exits over time
No timeline data for this period
Score Breakdown
25Deal Activity
22Track Record
20Visibility
0Profile
80Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Nexus NeuroTech Ventures?
Founded in 2023 by Jordi Parramon, PhD and William Marks, MD and with the addition of Jon Lundt, PhD, the firm brings a deep commitment to helping those with neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, such as Parkinson’s disease, bipolar disorder, and autism spectrum disorder. Adjacent to these sentinel disorders are many other brain disorders that are also within scope…
What kind of firm is Nexus NeuroTech Ventures?
Nexus NeuroTech Ventures is a Venture Capital.
Similar Investors